Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Parkinson disease"" wg kryterium: Temat


Tytuł :
Apathy in Parkinson disease: Why we should care.
Autorzy :
Friedman JH; From the Department of Neurology (J.H.F.), Movement Disorders Program, Butler Hospital, Warren Alpert Medical School of Brown University, Providence, RI; and Department of Neurology (C.G.G.), Rush University Medical Center, Rush University Medical School, Chicago, IL.
Goetz CG; From the Department of Neurology (J.H.F.), Movement Disorders Program, Butler Hospital, Warren Alpert Medical School of Brown University, Providence, RI; and Department of Neurology (C.G.G.), Rush University Medical Center, Rush University Medical School, Chicago, IL. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Nov 17; Vol. 95 (20), pp. 893-894. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Apathy*
Disruptive, Impulse Control, and Conduct Disorders*
Parkinson Disease*/epidemiology
Parkinson Disease*/therapy
Depression ; Humans
Opinia redakcyjna
Tytuł :
Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection.
Autorzy :
Méndez-Guerrero A; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain. .
Laespada-García MI; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Gómez-Grande A; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Ruiz-Ortiz M; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Blanco-Palmero VA; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Azcarate-Diaz FJ; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Rábano-Suárez P; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Álvarez-Torres E; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
de Fuenmayor-Fernández de la Hoz CP; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Vega Pérez D; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Rodríguez-Montalbán R; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Pérez-Rivilla A; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Sayas Catalán J; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Ramos-González A; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
González de la Aleja J; From the Departments of Neurology (A.M.-G., M.I.L.-G., M.R.-O., V.A.B.-P., F.J.Z.-D., P.R.-S, C.P.d.F.-F.d.l.H., J.G.d.l.A.), Nuclear Medicine (A.G.-G., D.V.P.), Anesthesiology (E.A.-T., R.R.-M.), Microbiology (A.P.-Z.), Pneumology (J.S.C.), and Neuroradiology (A.R.-G.), Hospital Universitario 12 de Octubre, Madrid, Spain.
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Oct 13; Vol. 95 (15), pp. e2109-e2118. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms :
Coronavirus Infections/*physiopathology
Parkinson Disease, Postencephalitic/*physiopathology
Pneumonia, Viral/*physiopathology
Putamen/*diagnostic imaging
Betacoronavirus ; Brain/diagnostic imaging ; Brain/metabolism ; Consciousness Disorders ; Coronavirus Infections/complications ; Coronavirus Infections/diagnostic imaging ; Disease Progression ; Dopamine Plasma Membrane Transport Proteins/metabolism ; Electroencephalography ; Humans ; Hypokinesia/diagnostic imaging ; Hypokinesia/etiology ; Hypokinesia/physiopathology ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Muscle Rigidity/diagnostic imaging ; Muscle Rigidity/etiology ; Muscle Rigidity/physiopathology ; Nortropanes ; Ocular Motility Disorders ; Pandemics ; Parkinson Disease, Postencephalitic/diagnostic imaging ; Parkinson Disease, Postencephalitic/etiology ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnostic imaging ; Putamen/metabolism ; Tomography, Emission-Computed, Single-Photon
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Reader response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
Autorzy :
van Rumund A; (Nijmegen, Netherlands).
Marques TM; (Nijmegen, Netherlands).
Esselink RAJ; (Nijmegen, Netherlands).
Bloem BR; (Nijmegen, Netherlands).
Verbeek MM; (Nijmegen, Netherlands).
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Oct 06; Vol. 95 (14), pp. 657-658.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Parkinson Disease*/diagnosis
Biomarkers ; Disease Progression ; Humans ; Neurofilament Proteins
Czasopismo naukowe
Tytuł :
Association of specific biotypes in patients with Parkinson disease and disease progression.
Autorzy :
Wang L; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Cheng W; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK. .
Rolls ET; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Dai F; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Gong W; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Du J; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Zhang W; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Wang S; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Liu F; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Wang J; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK.
Brown P; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK. .
Feng J; From the Institute of Science and Technology for Brain-inspired Intelligence (L.W., W.C., E.R., F.D, W.G., J. D., W.Z., S.W., J.F.), Fudan University; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (L.W., W.C., J. D., W.Z., S.W., J.F.) (Fudan University), Ministry of Education, Shanghai, China; Department of Computer Science (E.R., J.F.), University of Warwick, Coventry; Oxford Centre for Computational Neuroscience (E.R.), UK; Department of Neurology and National Clinical Research Center for Aging and Medicine (F.L., J.W.), Huashan Hospital, Fudan University, Shanghai, China; and Medical Research Council Brain Network Dynamics Unit (P.B.) and Nuffield Department of Clinical Neurosciences (P.B.), University of Oxford, UK. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Sep 15; Vol. 95 (11), pp. e1445-e1460. Date of Electronic Publication: 2020 Aug 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Progression*
Parkinson Disease/*diagnostic imaging
Parkinson Disease/*metabolism
Aged ; Cluster Analysis ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Parkinson Disease/classification ; Positron-Emission Tomography/trends ; Tomography, X-Ray Computed/trends
Czasopismo naukowe
Tytuł :
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
Autorzy :
Zach H; From the Department of Neurology (H.Z., M.F.D., J.W.P., B.R.B., R.C.H.), Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands; and Departments of Neurology (H.Z.) and Emergency Medicine (D.R.), Medical University Vienna, Austria.
Dirkx MF; From the Department of Neurology (H.Z., M.F.D., J.W.P., B.R.B., R.C.H.), Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands; and Departments of Neurology (H.Z.) and Emergency Medicine (D.R.), Medical University Vienna, Austria.
Roth D; From the Department of Neurology (H.Z., M.F.D., J.W.P., B.R.B., R.C.H.), Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands; and Departments of Neurology (H.Z.) and Emergency Medicine (D.R.), Medical University Vienna, Austria.
Pasman JW; From the Department of Neurology (H.Z., M.F.D., J.W.P., B.R.B., R.C.H.), Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands; and Departments of Neurology (H.Z.) and Emergency Medicine (D.R.), Medical University Vienna, Austria.
Bloem BR; From the Department of Neurology (H.Z., M.F.D., J.W.P., B.R.B., R.C.H.), Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands; and Departments of Neurology (H.Z.) and Emergency Medicine (D.R.), Medical University Vienna, Austria.
Helmich RC; From the Department of Neurology (H.Z., M.F.D., J.W.P., B.R.B., R.C.H.), Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands; and Departments of Neurology (H.Z.) and Emergency Medicine (D.R.), Medical University Vienna, Austria. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Sep 15; Vol. 95 (11), pp. e1461-e1470. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Controlled Clinical Trial; Journal Article
MeSH Terms :
Antiparkinson Agents/*therapeutic use
Dopamine Agents/*therapeutic use
Drug Resistance/*drug effects
Levodopa/*therapeutic use
Parkinson Disease/*drug therapy
Tremor/*drug therapy
Accelerometry ; Adult ; Aged ; Aged, 80 and over ; Double-Blind Method ; Drug Resistance/physiology ; Female ; Follow-Up Studies ; Humans ; Hypokinesia/diagnostic imaging ; Hypokinesia/drug therapy ; Hypokinesia/physiopathology ; Male ; Middle Aged ; Netherlands/epidemiology ; Parkinson Disease/diagnostic imaging ; Parkinson Disease/physiopathology ; Treatment Outcome ; Tremor/diagnostic imaging ; Tremor/physiopathology
Czasopismo naukowe
Tytuł :
β-Glucocerebrosidase activity in GBA -linked Parkinson disease: The type of mutation matters.
Autorzy :
Huh YE; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Chiang MSR; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Locascio JJ; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Liao Z; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Liu G; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Choudhury K; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Kuras YI; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Tuncali I; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Videnovic A; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Hunt AL; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Schwarzschild MA; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Hung AY; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Herrington TM; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Hayes MT; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Hyman BT; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Wills AM; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Gomperts SN; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Growdon JH; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Sardi SP; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston.
Scherzer CR; From the APDA Center for Advanced Parkinson Research (Y.E.H., J.J.L., Z.L., G.L., K.C., Y.I.K., I.T., M.T.H., C.R.S.) and Precision Neurology Program (Y.E.H., Z.L., G.L., Y.I.K., C.R.S.), Harvard Medical School, and Department of Neurology (Y.E.H., G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; Department of Neurology (Y.E.H.), CHA Bundang Medical Center, CHA University, Seongnam, Korea; Rare and Neurological Diseases Therapeutic Area (M.S.R.C., S.P.S.), Sanofi, Framingham, MA; School of Medicine (G.L.), Sun Yat-Sen University, Guangzhou, Guangdong, China; and Department of Neurology (J.J.L., A.V., A.L.H., M.A.S., A.Y.H., T.M.H., B.T.H., A.-M.W., S.N.G., J.H.G., C.R.S.), Massachusetts General Hospital, Boston. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Aug 11; Vol. 95 (6), pp. e685-e696. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
Glucosylceramidase/*genetics
Parkinson Disease/*genetics
Aged ; Aged, 80 and over ; Cognition Disorders/etiology ; Cross-Sectional Studies ; Female ; Follow-Up Studies ; Genetic Association Studies ; Glucosylceramidase/blood ; Humans ; Male ; Middle Aged ; Neurologic Examination ; Parkinson Disease/enzymology ; Parkinson Disease/physiopathology ; Parkinson Disease/psychology ; Quantitative Trait Loci ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Toward biomarker-based clinical subtyping of Parkinson disease.
Autorzy :
Lamotte G; From MedStar Georgetown University Hospital (G.L.), Department of Neurology, Washington, DC; and University of Electronic Science and Technology of China (B.B.), Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, Chengdu, China. .
Becker B; From MedStar Georgetown University Hospital (G.L.), Department of Neurology, Washington, DC; and University of Electronic Science and Technology of China (B.B.), Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, Chengdu, China.
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Sep 15; Vol. 95 (11), pp. 461-462. Date of Electronic Publication: 2020 Aug 14.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Parkinson Disease*/diagnosis
Biomarkers ; Disease Progression ; Humans
Opinia redakcyjna
Tytuł :
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
Autorzy :
Chahine LM; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany. .
Beach TG; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Brumm MC; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Adler CH; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Coffey CS; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Mosovsky S; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Caspell-Garcia C; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Serrano GE; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Munoz DG; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
White CL 3rd; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Crary JF; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Jennings D; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Taylor P; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Foroud T; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Arnedo V; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Kopil CM; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Riley L; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Dave KD; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Mollenhauer B; From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.
Pokaż więcej
Corporate Authors :
Systemic Synuclein Sampling Study
Źródło :
Neurology [Neurology] 2020 Sep 01; Vol. 95 (9), pp. e1267-e1284. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain/*diagnostic imaging
Colon/*metabolism
Parkinson Disease/*metabolism
Saliva/*metabolism
Skin/*metabolism
Submandibular Gland/*metabolism
alpha-Synuclein/*metabolism
Adult ; Aged ; Aged, 80 and over ; Biopsy ; Brain/metabolism ; Case-Control Studies ; Dopamine Plasma Membrane Transport Proteins ; Female ; Humans ; Male ; Middle Aged ; Parkinson Disease/diagnosis ; Sensitivity and Specificity ; Tomography, Emission-Computed, Single-Photon ; alpha-Synuclein/blood ; alpha-Synuclein/cerebrospinal fluid
Czasopismo naukowe
Tytuł :
Systemic Synuclein Sampling Study toward a Parkinson disease biomarker: Final results?
Autorzy :
Shinotoh H; From the Department of Functional Brain Imaging (H.S., T.T.), National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba; and Neurology Clinic Chiba (H.S.), Japan. .
Tokuda T; From the Department of Functional Brain Imaging (H.S., T.T.), National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba; and Neurology Clinic Chiba (H.S.), Japan.
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Sep 01; Vol. 95 (9), pp. 373-374. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Parkinson Disease*
alpha-Synuclein*
Biomarkers ; Humans ; Sampling Studies
Opinia redakcyjna
Tytuł :
NfL as a biomarker for neurodegeneration and survival in Parkinson disease.
Autorzy :
Bäckström D; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK. .
Linder J; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK.
Jakobson Mo S; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK.
Riklund K; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK.
Zetterberg H; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK.
Blennow K; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK.
Forsgren L; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK.
Lenfeldt N; From the Department of Clinical Science (D.B., J.L., L.F., N.L.), Neurosciences, and Department of Radiation Sciences (S.J.M., K.R.), Diagnostic Radiology and Umeå Center for Functional Brain Imaging, Umeå University; Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Queen Square Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London, UK.
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Aug 18; Vol. 95 (7), pp. e827-e838. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers/*blood
Neurofilament Proteins/*metabolism
Parkinson Disease/*diagnosis
Parkinsonian Disorders/*diagnosis
Adult ; Aged ; Diffusion Tensor Imaging/methods ; Disease Progression ; Dopamine Plasma Membrane Transport Proteins/metabolism ; Female ; Humans ; Male ; Middle Aged ; Parkinson Disease/metabolism
Czasopismo naukowe
Tytuł :
Author response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
Autorzy :
Narendra DP; (Bethesda, Maryland).
Isonaka R; (Bethesda, Maryland).
Nguyen D; (Bethesda, Maryland).
Schindler AB; (Bethesda, Maryland).
Kokkinis AD; (Bethesda, Maryland).
Ehrlich D; (Bethesda, Maryland).
Bardakjian TM; (Philadelphia).
Goldstein DS; (Bethesda, Maryland).
Liang TW; (Philadelphia).
Gonzalez-Alegre P; (Philadelphia).
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 May 26; Vol. 94 (21), pp. 944.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Cataract*
Hearing Loss*
Parkinson Disease*
Synucleinopathies*
Humans
Czasopismo naukowe
Tytuł :
Reader response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
Autorzy :
Namnah M; (Jerusalem).
Elpeleg O; (Jerusalem).
Gotkine M; (Jerusalem).
Arkadir D; (Jerusalem).
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 May 26; Vol. 94 (21), pp. 943-944.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Cataract*
Hearing Loss*
Parkinson Disease*
Synucleinopathies*
Humans
Czasopismo naukowe
Tytuł :
Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.
Autorzy :
Mappin-Kasirer B; From the Clinical Trial Service Unit and Epidemiological Studies Unit (B.M.-K., H.P., S.L., J.K., R.G., R.C., R.P.), Nuffield Department of Population Health, University of Oxford; and Medical Research Council Population Health Research Unit (H.P., S.L.), Nuffield Department of Population Health, University of Oxford, United Kingdom.
Pan H; From the Clinical Trial Service Unit and Epidemiological Studies Unit (B.M.-K., H.P., S.L., J.K., R.G., R.C., R.P.), Nuffield Department of Population Health, University of Oxford; and Medical Research Council Population Health Research Unit (H.P., S.L.), Nuffield Department of Population Health, University of Oxford, United Kingdom.
Lewington S; From the Clinical Trial Service Unit and Epidemiological Studies Unit (B.M.-K., H.P., S.L., J.K., R.G., R.C., R.P.), Nuffield Department of Population Health, University of Oxford; and Medical Research Council Population Health Research Unit (H.P., S.L.), Nuffield Department of Population Health, University of Oxford, United Kingdom.
Kizza J; From the Clinical Trial Service Unit and Epidemiological Studies Unit (B.M.-K., H.P., S.L., J.K., R.G., R.C., R.P.), Nuffield Department of Population Health, University of Oxford; and Medical Research Council Population Health Research Unit (H.P., S.L.), Nuffield Department of Population Health, University of Oxford, United Kingdom.
Gray R; From the Clinical Trial Service Unit and Epidemiological Studies Unit (B.M.-K., H.P., S.L., J.K., R.G., R.C., R.P.), Nuffield Department of Population Health, University of Oxford; and Medical Research Council Population Health Research Unit (H.P., S.L.), Nuffield Department of Population Health, University of Oxford, United Kingdom.
Clarke R; From the Clinical Trial Service Unit and Epidemiological Studies Unit (B.M.-K., H.P., S.L., J.K., R.G., R.C., R.P.), Nuffield Department of Population Health, University of Oxford; and Medical Research Council Population Health Research Unit (H.P., S.L.), Nuffield Department of Population Health, University of Oxford, United Kingdom. .
Peto R; From the Clinical Trial Service Unit and Epidemiological Studies Unit (B.M.-K., H.P., S.L., J.K., R.G., R.C., R.P.), Nuffield Department of Population Health, University of Oxford; and Medical Research Council Population Health Research Unit (H.P., S.L.), Nuffield Department of Population Health, University of Oxford, United Kingdom.
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 May 19; Vol. 94 (20), pp. e2132-e2138. Date of Electronic Publication: 2020 May 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Parkinson Disease/*epidemiology
Physicians/*statistics & numerical data
Smoking/*adverse effects
Tobacco Smoking/*adverse effects
Adult ; Age Factors ; Aged ; Cohort Studies ; Ethnic Groups ; Humans ; Male ; Middle Aged ; Parkinson Disease/etiology ; Risk Factors ; Smoking/epidemiology ; Smoking Cessation ; Time Factors
Czasopismo naukowe
Tytuł :
Dementia with Lewy bodies and Parkinson disease dementia: More different than similar?
Autorzy :
Armstrong MJ; From the Department of Neurology (M.J.A.), University of Florida College of Medicine, Gainesville, FL; and Behavioral Neurology and Movement Disorders Unit (M.E.), Department of Neurology, Istanbul Faculty of Medicine, Istanbul, Turkey. melissa.armstrong@neurology.ufl.edu.
Emre M; From the Department of Neurology (M.J.A.), University of Florida College of Medicine, Gainesville, FL; and Behavioral Neurology and Movement Disorders Unit (M.E.), Department of Neurology, Istanbul Faculty of Medicine, Istanbul, Turkey.
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 May 19; Vol. 94 (20), pp. 858-859. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Cognitive Dysfunction*
Lewy Body Disease*
Parkinson Disease*
Humans ; Lewy Bodies
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies